[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 6 of about 6
1. Tanaka F, Li M, Hanaoka N, Bando T, Fukuse T, Hasegawa S, Wada H: Surgery for pulmonary nodules in breast cancer patients. Ann Thorac Surg; 2005 May;79(5):1711-4; discussion 1714-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The pathologic diagnoses of pulmonary nodules were pulmonary metastases of breast cancer in 39 patients, primary lung cancer in 6, and other diagnoses in 7 (tuberculosis and hamartoma in 2 each; sclerosing hemangioma, organizing pneumonia, and paragohimiasis in 1 each).
  • The 5-year survival rate after pulmonary metastectomy of metastatic breast cancer patients was 30.8%, which was not better than those documented in metastatic breast cancer patients treated with modern chemotherapy.
  • CONCLUSIONS: Pulmonary metastectomy may not be the primary therapeutic option in metastatic breast cancer patients, and patients should be treated principally with chemotherapy.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15854960.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


2. Guo J, Wu H: [An experimental study on the blood vessel sclerosing therapeutic agents for cavernous hemangiomas]. Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug;19(4):256-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [An experimental study on the blood vessel sclerosing therapeutic agents for cavernous hemangiomas].
  • OBJECTIVE: This study was designed to test what are the suitable drugs for sclerotherapy and investigate the formation mechanism of cavernous hemangiomas.
  • The rabbits of the control were injected with physiological saline, and the rabbits of the experimental groups were injected respectively with various drugs, including 5% sodium morrhuate, 10% alum, pinyungmycin, leurocristine and the combination of pinyungmycin and dexamethasone.
  • RESULTS: According to histopathological changes of tissue, 5% sodium morrhuate, 10% alum, and the combination of pinyungmycin and dexamethasone produced better eutherapeutic effects, when comparing with other methods.
  • However, 5% sodium morrhuate caused tissue necrosis of the injection site.
  • CONCLUSION: The combined therapy of pinyungmycin and dexamethasone produced excellent sclerotic effects.
  • Whatever drugs causing serious damage of HVEC may contribute to the therapy for cavernous hemangiomas.
  • [MeSH-major] Hemangioma, Cavernous / therapy. Sclerotherapy
  • [MeSH-minor] Animals. Bleomycin / administration & dosage. Bleomycin / analogs & derivatives. Dexamethasone / administration & dosage. Drug Therapy, Combination. Ear / blood supply. Rabbits. Veins / pathology

  • Hazardous Substances Data Bank. BLEOMYCIN .
  • Hazardous Substances Data Bank. DEXAMETHASONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12539736.001).
  • [ISSN] 1000-1182
  • [Journal-full-title] Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology
  • [ISO-abbreviation] Hua Xi Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 11056-06-7 / Bleomycin; 7S5I7G3JQL / Dexamethasone
  •  go-up   go-down


3. Kim KH, Sul HJ, Kang DY: Sclerosing hemangioma with lymph node metastasis. Yonsei Med J; 2003 Feb;44(1):150-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sclerosing hemangioma with lymph node metastasis.
  • Sclerosing hemangioma (SH) of the lung is an uncommon type of tumor, which is composed of polygonal and cuboidal cells.
  • Both types of tumor cells were uniformly immunoreactive to the epithelial membrane antigen (EMA) and the thyroid transcription factor-1 (TTF-1).
  • Postoperatively, the patient received chemotherapy and no recurrence or metastasis 2 years after surgery was noted.
  • [MeSH-major] Hemangioma / pathology. Lung Neoplasms / pathology. Lymphatic Metastasis


Advertisement
4. Miyagawa-Hayashino A, Tazelaar HD, Langel DJ, Colby TV: Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases. Arch Pathol Lab Med; 2003 Mar;127(3):321-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases.
  • CONTEXT: Sclerosing hemangioma is an unusual pulmonary tumor.
  • Previously, 4 patients with pulmonary sclerosing hemangioma and lymph node metastases have been described in the literature.
  • OBJECTIVE: To report 4 additional cases of metastatic sclerosing hemangioma.
  • RESULTS: Four cases of a morphologically benign pulmonary sclerosing hemangioma with regional lymph node metastases (including hilar, peribronchial, and interlobar metastases) were identified.
  • The pulmonary tumors were typical circumscribed sclerosing hemangiomas without mitotic activity, angiolymphatic invasion, or necrosis.
  • One patient received adjuvant chemotherapy for adenocarcinoma.
  • CONCLUSIONS: On the basis of case data from the 4 patients described here and the 4 patients described previously, metastases to regional lymph nodes from pulmonary sclerosing hemangioma may occur but are rare and do not appear to affect prognosis.
  • [MeSH-major] Hemangioma / diagnosis. Lung Neoplasms / diagnosis. Lymph Nodes / pathology

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12653576.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Baud AV, Breton P, Guibaud L, Freidel M: [Treatment of low-pressure vascular malformations by injection of Ethibloc. Study of 19 cases and analysis of complications]. Rev Stomatol Chir Maxillofac; 2000 Oct;101(4):181-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Treatment of low-pressure vascular malformations by injection of Ethibloc. Study of 19 cases and analysis of complications].
  • [Transliterated title] Traitement des malformations vasculaires à bas débit par injection d'Ethibloc. Etude de 19 cas et analyse des complications.
  • Post-treatment complications consisted in a local inflammatory reaction.
  • These satisfactory results (volume decreasing in 90% of the malformations) as well as the mildness of the side effects encourage to use Ethibloc in the treatment of low flow vascular malformations.
  • In our experience, Ethibloc is particularly appropriate for the treatment of large lymphangiomas.
  • [MeSH-major] Arteriovenous Malformations / therapy. Diatrizoate / therapeutic use. Fatty Acids / therapeutic use. Lymphangioma, Cystic / therapy. Propylene Glycols / therapeutic use. Sclerosing Solutions / therapeutic use. Sclerotherapy / methods. Zein / therapeutic use
  • [MeSH-minor] Adult. Child. Child, Preschool. Drug Combinations. Female. Granuloma / etiology. Head and Neck Neoplasms / therapy. Hemangioma / therapy. Humans. Infant. Infant, Newborn. Lung Neoplasms / therapy. Male. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Vascular Malformations.
  • MedlinePlus Health Information. consumer health - Arteriovenous Malformations.
  • Hazardous Substances Data Bank. DIATRIZOATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11103425.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] FRANCE
  • [Chemical-registry-number] 0 / Drug Combinations; 0 / Fatty Acids; 0 / Propylene Glycols; 0 / Sclerosing Solutions; 117-96-4 / Diatrizoate; 9010-66-6 / Zein; 91196-33-7 / alcoholic prolamine solution
  •  go-up   go-down


6. Meziane M, Boulaadas M, Eabdenbitsen A, Dib N, Essakalli L, Kzadri M: [Intramasseteric hemangioma operated by intraoral approach]. Rev Stomatol Chir Maxillofac; 2010 Jun;111(3):168-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intramasseteric hemangioma operated by intraoral approach].
  • [Transliterated title] Hémangiome du masséter opéré par voie intra-orale.
  • In this case, treatment is usually surgery via an extra-oral approach which imposes parotidectomy with dissection of facial nerve branches.
  • We report a case of intramasseteric hemangioma operated via an intraoral approach and we describe the benefits of this approach.
  • DISCUSSION: Intraoral intramasseteric hemangioma exeresis is possible and does not seem to lead to more complications than with the facial approach.
  • [MeSH-major] Hemangioma / diagnosis. Masseter Muscle / pathology. Muscle Neoplasms / diagnosis
  • [MeSH-minor] Adult. Angiography. Combined Modality Therapy. Diatrizoate / therapeutic use. Drug Combinations. Embolization, Therapeutic. Fatty Acids / therapeutic use. Follow-Up Studies. Humans. Male. Oral Surgical Procedures / methods. Propylene Glycols / therapeutic use. Sclerosing Solutions / therapeutic use. Tomography, X-Ray Computed. Zein / therapeutic use

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • Hazardous Substances Data Bank. DIATRIZOATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20553891.001).
  • [ISSN] 1776-257X
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Drug Combinations; 0 / Fatty Acids; 0 / Propylene Glycols; 0 / Sclerosing Solutions; 117-96-4 / Diatrizoate; 9010-66-6 / Zein; 91196-33-7 / alcoholic prolamine solution
  •  go-up   go-down






Advertisement